Related Experiment Video
Updated: Oct 1, 2025
08:25
Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
Published on: April 7, 2015
9.2K
Cardiac Complications Associated with COVID-19, MIS-C, and mRNA COVID-19 Vaccination
Stephanie E Chin1,2,3, Sejal M Bhavsar4,5, Andrew Corson6
1K. Hovnanian Children's Hospital at Jersey Shore University Medical Center, Neptune, NJ, USA. schin@alpertzalescastro.com.
Pediatric Cardiology
|March 8, 2022
Summary
COVID-19 vaccination is recommended for children over 5. Vaccine-related myocarditis is mild and treatable, unlike severe cardiac issues from COVID-19 infection or MIS-C.
Area of Science:
- Pediatric Medicine
- Vaccinology
- Cardiology
Background:
- COVID-19 vaccination is approved for children over 5, yet uptake is low.
- Vaccine hesitancy is fueled by misinformation and concerns about myocarditis.
- Myocarditis following COVID-19 infection or MIS-C poses greater cardiac risks than vaccine-associated myocarditis.
Purpose of the Study:
- To compare the risks of cardiac complications from COVID-19 infection versus mRNA COVID-19 vaccination in children.
- To address vaccine hesitancy by clarifying the safety profile of pediatric COVID-19 vaccination.
Main Methods:
- Comparative analysis of clinical outcomes.
- Review of existing literature on myocarditis and cardiovascular complications.
- Assessment of disease severity and prognosis.
Main Results:
- Vaccine-associated myocarditis presents mildly, is treatable, and has a good prognosis.
- Acute COVID-19 and MIS-C are linked to more severe and frequent cardiac complications, including myocarditis and myocardial injury.
- COVID-19 infection poses a significantly higher risk for severe cardiovascular outcomes in children.
Conclusions:
- COVID-19 vaccination is a safer alternative to natural infection regarding cardiac complications.
- Widespread pediatric vaccination can mitigate severe illness, MIS-C, and associated disruptions.
- COVID-19 vaccination is strongly recommended for all eligible pediatric age groups.
Related Concept Videos
01:14Myocarditis III: Medical Management
27
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
27
01:21Myocarditis I: Introduction
52
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
52
01:30Coronary Artery Disease III: Clinical Manifestations
53
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
53
01:25Cardiomyopathy I: Introduction and Classification
99
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
99
01:27Myocarditis II: Clinical Features and Diagnostic Tests
36
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
36
01:23Mitral Regurgitation II: Clinical Features and Diagnostic Tests
68
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
68